Invention Grant
- Patent Title: Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase
- Patent Title (中): 嘧啶并哒嗪酮衍生物，用于治疗受到激酶抑制影响的疾病
-
Application No.: US14602921Application Date: 2015-01-22
-
Publication No.: US09403799B2Publication Date: 2016-08-02
- Inventor: Oliver Schadt , Dieter Dorsch , Frank Stieber , Andree Blaukat
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: MERCK PATENT GMBH
- Current Assignee: MERCK PATENT GMBH
- Current Assignee Address: DE Darmstadt
- Agency: Millen White Zelano and Branigan, PC
- Agent Csaba Henter; Anthony Zelano
- Priority: DE102007032507 20070712; WOPCT/EP2008/003473 20080429
- Main IPC: A61K47/02
- IPC: A61K47/02 ; A61K9/08 ; A61K9/19 ; C07D417/10 ; C07D451/06 ; C07D409/14 ; C07D405/14 ; C07D453/02 ; C07D413/10 ; C07D403/14 ; C07D403/10 ; C07D401/10 ; C07D401/14 ; C07D413/14 ; C07D417/14 ; A61K31/501 ; A61K31/506 ; A61K31/5355 ; A61K31/5377 ; A61K31/55 ; A61K45/06 ; A61K9/00 ; A61K9/02 ; A61K9/06 ; A61K9/20 ; A61K9/28
Abstract:
Compounds selected from the group according to claim 1 are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed, inter alia, for the treatment of tumors.
Public/Granted literature
- US20150133452A1 PYRIMIDINYL PYRIDAZINONE DERIVATIVES Public/Granted day:2015-05-14
Information query
